Skip to main content
Top
Published in: HSS Journal ® 1/2012

Open Access 01-02-2012 | HSS OSTEOARTHRITIS SYMPOSIUM: FRONTIERS IN OA

Industry Perspective on OA

Author: Ed. E. C. Margerrison, PhD

Published in: HSS Journal ® | Issue 1/2012

Login to get access

Excerpt

The progressive degenerative changes associated with osteoarthritis (OA) can arise from age-related chronic degeneration or can be triggered by traumatic changes in the articular cartilage and/or subchondral bone. Traditionally, the orthopaedics industry has intervened in this disease progression only in the latter stages with joint replacements, but the picture has been changing over the last few years with the development of novel products and techniques. In addition to arthroplasty, the orthopaedics industry is now considering three alternative points of intervention in the disease, namely: (1) pain treatment; (2) disease progression; and (3) treatment of cartilage and osteochondral trauma, all essentially allowing for preservation of the joint. Whilst joint arthroplasty remains an extremely successful treatment option, a realistic aim of the healthcare industry must be to prevent disease progression, through early intervention allowing for a more complete return to function for patients. …
Literature
1.
go back to reference Adkisson HD 4th, Martin JA, Amendola RL, Milliman C, Mauch KA, Katwal AB, Seyedin M, Amendola A, Streeter PR, Buckwalter JA. The potential of human allogeneic juvenile chondrocytes for restoration of articular cartilage.. Am J Sports Med 2010;38:1324-33.PubMedCrossRef Adkisson HD 4th, Martin JA, Amendola RL, Milliman C, Mauch KA, Katwal AB, Seyedin M, Amendola A, Streeter PR, Buckwalter JA. The potential of human allogeneic juvenile chondrocytes for restoration of articular cartilage.. Am J Sports Med 2010;38:1324-33.PubMedCrossRef
2.
go back to reference Farr J II, Yao JQ. Chondral defect repair with particulated juvenile cartilage allograft. Cartilage 2011;2:346–353. Farr J II, Yao JQ. Chondral defect repair with particulated juvenile cartilage allograft. Cartilage 2011;2:346–353.
3.
go back to reference Strand, V., et al. A multicenter, randomized controlled trial comparing a single intra-articular injection of Gel-200, a new cross-linked formulation of hyaluronic acid, to phosphate buffered saline for treatment of osteoarthritis of the knee. Osteoarthritis and Cartilage 2011 (in press). Strand, V., et al. A multicenter, randomized controlled trial comparing a single intra-articular injection of Gel-200, a new cross-linked formulation of hyaluronic acid, to phosphate buffered saline for treatment of osteoarthritis of the knee. Osteoarthritis and Cartilage 2011 (in press).
Metadata
Title
Industry Perspective on OA
Author
Ed. E. C. Margerrison, PhD
Publication date
01-02-2012
Publisher
Springer-Verlag
Published in
HSS Journal ® / Issue 1/2012
Print ISSN: 1556-3316
Electronic ISSN: 1556-3324
DOI
https://doi.org/10.1007/s11420-011-9265-5

Other articles of this Issue 1/2012

HSS Journal ® 1/2012 Go to the issue

HSS OSTEOARTHRITIS SYMPOSIUM: FRONTIERS IN OA

Osteoarthritis as a Whole Joint Disease

HSS OSTEOARTHRITIS SYMPOSIUM: FRONTIERS IN OA

Articular Cartilage Degradation in Osteoarthritis

HSS Osteoarthritis Symposium: Frontiers in OA

Biomarkers in Osteoarthritis

HSS Osteoarthritis Symposium: Frontiers in OA

MR Imaging Tools to Assess Cartilage and Joint Structures

HSS OSTEOARTHRITIS SYMPOSIUM: FRONTIERS IN OA

Periarticular Bone Changes in Osteoarthritis